Jeffrey Schwartz's most recent trade in Kestra Medical Technologies Ltd. was a trade of 7,217 Common Shares done . Disclosure was reported to the exchange on Sept. 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kestra Medical Tech Ltd | Jeffrey Schwartz | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2026 | 7,217 | 14,236 | - | - | Common Shares | |
| Kestra Medical Tech Ltd | Jeffrey Schwartz | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.18 per share. | 08 Sep 2026 | 3,890 | 7,019 | - | 25.2 | 97,942 | Common Shares |
| Kestra Medical Tech Ltd | Jeffrey Schwartz | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 10,909 | 10,909 | - | - | Common Shares | |
| Tucows Inc (Class A) | Jeffrey Schwartz | Director | 20 Jun 2024 | 3,750 | 3,750 | - | - | Stock Option (Right to Buy) | ||
| Rapid Micro Biosystems Inc (Class A) | Jeffrey Schwartz | Director, Ten Percent Owner | 23 May 2024 | 28,650 | 28,650 | - | - | Stock Option (Right to Buy) | ||
| Rapid Micro Biosystems Inc (Class A) | Jeffrey Schwartz | Director, Ten Percent Owner | 23 May 2024 | 14,300 | 14,300 | - | 0 | Class A Common Stock | ||
| SpringWorks Therapeutics Inc | Jeffrey Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 13,774 | 13,774 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Jeffrey Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 4,648 | 10,572 (0%) | 0% | 0 | Common Stock | |
| SpringWorks Therapeutics Inc | Jeffrey Schwartz | Director | Sale of securities on an exchange or to another person at price $ 28.50 per share. | 16 Mar 2023 | 1,750,000 | 3,081,307 (7%) | 4% | 28.5 | 49,875,000 | Common Stock |
| Tucows Inc (Class A) | Jeffrey Schwartz | Director | 08 Sep 2022 | 3,750 | 3,750 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | Jeffrey Schwartz, | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 15,318 | 15,318 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Jeffrey Schwartz, | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 4,818 | 5,924 (0%) | 0% | 0 | Common Stock |